[Angiotensin resistance. Critical remarks on the so called Bartter syndrome].
D000328:Adult; D000368:Aged; D000471:Alkalosis / Q000175:diagnosis; D000804:Angiotensin II / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001795:Blood Pressure Determination; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis*; D006965:Hyperplasia; D006984:Hypertrophy; D007008:Hypokalemia / Q000175:diagnosis / Q000188:drug therapy; D007606:Juxtaglomerular Apparatus; D007674:Kidney Diseases / Q000175:diagnosis*; D009638:Norepinephrine / Q000494:pharmacology; D010783:Photometry; D011188:Potassium / Q000097:blood / Q000494:pharmacology; D011189:Potassium Chloride / Q000627:therapeutic use
D000804:Angiotensin II; D011189:Potassium Chloride; D011188:Potassium; D009638:Norepinephrine
Zur Frage der Angiotensinresistenz. Kritsche Anmerkung zum sogenannten Bartter-Syndrom.